Efficacy and safety of LixiLan, a titratable fixed-ratio combination of lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: The LixiLan proof-of-Concept randomized trial
Scientifically, they work by mimicking a natural hormone in your body called glucagon-like peptide-1, which is released in the gut after you eat
However, this lipid tail also affects the peptide solubility characteristics
The discount is applied at the pharmacy and can reduce your monthly payment to around $25, subject to caps of $100 for a 1-month supply, $200 for a 2-month supply, or $300 for a 3-month supply
A study conducted on 76 patients with advanced CKD (stage 4 or higher) who began semaglutide treatment between January 2018 and January 2023 revealed that many safely reached therapeutic doses